Astri Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Operating Expenses | 13,493 | 14,290 | 12,386 | 11,449 | 15,378 |
Operating Income | -13,493 | -14,290 | -12,386 | -11,449 | -15,378 |
Other Income | 2,305 | 1,026 | 389 | 199 | 55 |
Pre-tax Income | -11,188 | -13,264 | -11,997 | -11,250 | -15,323 |
Net Income Continuous | -11,188 | -13,264 | -11,997 | -11,250 | -15,323 |
Net Income | $-11,188 | $-13,264 | $-11,997 | $-11,250 | $-15,323 |
EPS Basic Total Ops | -0.40 | -0.64 | -0.87 | -0.86 | -1.18 |
EPS Basic Continuous Ops | -0.40 | -0.63 | -0.87 | -0.86 | -1.18 |
EPS Diluted Total Ops | -0.40 | -0.64 | -0.87 | -0.86 | -1.18 |
EPS Diluted Continuous Ops | -0.40 | -0.63 | -0.87 | -0.86 | -1.18 |
EPS Diluted Before Non-Recurring Items | -0.40 | -0.72 | -0.87 | N/A | N/A |
EBITDA(a) | $-13,493 | $-14,290 | $-12,386 | $-11,449 | $-15,378 |